A Review Article on Proniosome: As A Drug Carrier
DOI:
https://doi.org/10.22270/ajprd.v9i4.1010Keywords:
Proniosome, Advantage, Application, Methodology, Drug carrierAbstract
A drug carrier is any substrate used in the process of drug delivery.
The basic component of the drug delivery system is an appropriate drug carrier that sets out to improve the selectivity, effectiveness, and safety of drug administration. So, based on their biocompatible, biodegradable, and non-immunogenic structure, Proniosomes are promising drug carriers that are non-ionic surfactant-based multilamellar or unilamellar vesicle are now widely used as an alternative to the liposome. On the basis of structure, they are similar to liposomes in having bilayer but having chemical differences in monomer units which make Proniosomes stable. They can entrap both hydrophilic and lipophilic drugs of using either in an aqueous layer or in the vesicular membrane. Proniosomal carriers are suitable for the transdermal delivery of numerous pharmacological agents, including antioxidant, anticancer, anti-inflammatory, antimicrobial, and antibacterial molecules.
Downloads
References
2. Pal P; Dr. Mishra S. Formulation and Development of Antifungal Proniosomal Gel for Topical Application. World Journal of Pharmaceutical Research, 2017; 6(5): 656-674.
3. Katare O, Vyas S, Dixit V. Effervescent granule based proliposome of Ibuprofen. Journal of Microencapsulation, 1990; 7(4): 455-62.
4. Payne N, Browning I, Hynes, C. Characterization of proliposome. Journal of Pharmaceutical Science, 1986; 75(4): 330 – 333.
5. Dr. Mangilal T. T., Patnik KSK, Kumar SM, Thirupati L, Nagaraju I. Preparation and Evaluation of Proniosomal Rosuvastatin Gel for Transdermal Delivery. World Journal of Pharmaceutical Research, 2015; 4(6): 2309-2322.
6. Nimbalwar M, Upadhyay K and Dixit G. Fabrication and Evaluation of Antihistaminic Activity of Proniosome Bases Transdermal Patches. Pharmacophore-A International Research Journal, 2016; 7(2): 82-95.
7. Hardia Aarti, Jamindar D, Mahajan A, Hardia A. Formulation and In-vitro and Skin Permeability Evaluation of Dexamethasone Loaded Niosomal Gel. Asian Journal of Pharmaceutical Research and Development, 2017; 5(2): 01-09.
8. Vardhani CHS, Niraosha M, Chandrasekhar K.B. Proniosomal Gel – An Effective Approach for Topical and Transdermal Drug Delivery. International Journal of Research and Pharmaceutical Science, 2016; 7(2): 179-188.
9. Gupta A, Prajapati SK, Balamurugan M, Singh M, Bhatia D. Design and Development of a Proniosomal Transdermal Drug Delivery System. Tropical Journal of Pharmaceutical Research, 2007; 6(2): 687-693.
10. Sagar S, Lavanya S, Sagar V, Dr. Nanjwade BK. Indo American Journal of Pharmaceutical Sciences. Indo American Journal of Pharmaceutical Sciences, 2017; 4(8): 2513-2520.
11. Sengodan T, Biradar S, Rathi V, Rathi JC. Formulation and Evaluation of Maltodextrin. Journal of Pharmatech Research, 2009; 1(3): 517-523.
12. Sulthana AA, George BJ, Samuel J. International Journal of Pharmaceutical, Chemical, and Biological Science, 2015; 5(4): 879-882.
13. Pandit P. G, Parakh D. R, Patil M. P. Proniosomal Gel for improved Transdermal Drug Delivery: An Overview. World Journal of Pharmaceutical Research, 2015; 4(8): 560-586.
14. Ramakanth S, Chetty M. C, Sudhakar Y, Thiruvengadrajan V. S, Amitha P, Gopinath C. Development and In-vivo Evaluation of Proniosomal Based Transdermal Delivery System of Atenolol. Future Journal of Pharmaceutical Science, 2018; 4(3): 80-87.
15. Kumar K, Rai AK. Development and Evaluation of Proniosome Encapsulated Curcumin for Transdermal Administration. Tropical Journal of Pharmaceutical Research, 2011; 10(6): 697-703.
16. Soujanya C, Prakash R. P. Formulation and Evaluation of Proniosomal Gel Based Transdermal Delivery of Atorvastatin Calcium by Box-Behnken Design. Asian Journal of Pharmaceutical and Clinical Research, 2019; 12(4): 335-43.
17. Munish A, Kamal S. Proniosomes Formulations Using Maltodextrin and Mannitol as Carriers. International Journal of Pharmaceutical and Chemical sciences, 2014; 3(2): 547-551.
18. Sivaprasad S. N. D, Lakshman P. K, Srinivas M, B. Brahmaiah, Sreekanth Nama. Proniosome: A Novel Approach to Vesicular Drug Delivery System. International Journal of Innovative Drug Discovery, 2013; 3(2): 85-90.
19. Shehata T. M, Ibrahim M. M, Elsewedy H. S. Curcumin Niosomes Prepared from Proniosomal Gels: In-vitro Skin Permeability, Kinetic and In-vivo Studies. Polymers, 2021; 13: 1-14.
20. Bhama S, Sambath R. K. Development and Evaluation of Letrozole Loaded Proniosomes as Drug delivery System. International journal of Research in Pharmaceutical Sciences, 2016; 6(4): 363-368.
21. Kumar Sunil, Jain P. K, Pandey N, Saxena G. Comparative Study of Proniosomal Drug Delivery System of Flurbiprofen. Journal of Chemical and Pharmaceutical Research, 2016; 8(5): 222-228.
22. Dr. Deepu S, Dr. Kurichan M. A, Sreekavya B. Formulation and Evaluation of Antihistaminic Activity of Proniosome Based Transdermal Patches. International Journal Research and Review, 2018; 5(10): 177-188.
23. Boddy M, Choppri V, Vamshi R. K, Badam M. Formulation and Evaluation of Proniosome of Felodipine. Drug Des, an open access journal, 2017; 6(3): 1-9.
24. Sammour R. M. F, Taher M, Chatterjee B, Shahiwala A, Mahmood S. Optimization of Aceclofenac Proniosomes by Using Different Carriers. MDPI- Pharmaceutics, 2019; 350(11): 1-19.
25. Hu C, Rhodes DG. Proniosomes: a novel drug carrier preparation. International J Pharm, 1999; 206(1-2): 23–35.
26. Raju J, Karthik YJ, Ashok V, et al. Bioavailability enhancement of zaleplon via proliposome: Role of surface charge. European Journal of Pharm BioPharma, 2012; 80: 347–57.
27. Srikanth, Kumar A. Y, Setty M. C. Formulation and Evaluation of Maltodextrin Bases Doxorubicin HCl Proniosomes. Research Journal Pharm and Tech, 2019; 12(6):
28. Dhangar R. K, Mishra S. S, Pathak A, Raghuvanshi N, Yagnik S. K, Dubey A, Rawat D. Formulation and Evaluation of Proniosomal Gel in Ocular Drug. Current Research in Pharmaceutical Science, 2012; 5(2): 42-47.
29. Solanki AB, Parikh JR, Parikh RH. Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level box-Behnken design. AAPS Pharm Sci Tech 2007; 8(4): 1–7.
30. KUMAR A, Parthiban S, and Kumar G. P. S. European Journal of Biomedical and Pharmaceutical Sciences, 2016; 3(5): 362-374.
31. Jampala R, Radha GY, Trideva SK, Burada S. Asian Journal of Pharmaceutical, and Clinical Research, 2019; 12(1): 54-61.
32. Mokhtar M, Sammour OA, Hammad MA, et al. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm, 2008; 361(1-2):104–11.
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.